Bone health
References
1 Heaney, R., et al. 2003. Human serum 25-hydroxycholecalciferol response
to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr., 77, 204–210.
URL: http://www.ajcn.org/cgi/content/full/77/1/204 (accessed 10.13.2008).
2 Brown, S. 2008. Vitamin D and fracture reduction: An evaluation of
the existing research. Alt. Med. Rev. 13 (1), 21–33. URL (PDF): http://www.thorne.com/altmedrev/.fulltext/13/1/21.pdf
(accessed 10.13.2008).
3 Vermeer, C., et al. 1995. Role of vitamin K in bone metabolism. Annu.
Rev. Nutr., 15 , 1–22. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/8527213
(accessed 10.13.2008).
4 Knapen, M., et al. 1993. Vitamin K-induced changes in markers for osteoblast
activity and urinary calcium loss. Calcif. Tissue Int., 53 (2), 81–85.
URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/8402326 (accessed 08.12.2008).
5 Szulc, P., et al. 1993. Serum undercarboxylated osteocalcin is a marker
of the risk of hip fracture in elderly women. J. Clin. Invest., 9 (4),
1769–1774. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8473517
(accessed 10.13.2008).
6 Knapen, M., et al. 1993.
7 Kalkwarf, J., et al. 2004. Vitamin K, bone turnover, and bone mass
in girls. Am. J. Clin. Nutr., 80 (4), 1075–1080. URL: http://www.ajcn.org/cgi/content/full/80/4/1075
(accessed 08.12.2008).
8 Booth, S., & Suttle, J. 1998. Dietary intake adequacy of vitamin
K1. J. Nutr., 128 (5), 785–788. URL: http://jn.nutrition.org/cgi/content/full/128/5/785
(accessed 10.13.2008).
9 Booth, S., et al. 1995. Assessment of dietary phylloquinone intake
and vitamin K status in postmenopausal women. Eur. J. Clin. Nutr, 49 (11),
832–841. URL: http://www.ncbi.nlm.nih.gov/pubmed/8557021 (accessed 08.12.2008).
10 Seelig, M. 1980. Magnesium deficiency in the pathogenesis of disease.
New York: Plenum Press. URL: http://www.mgwater.com/Seelig/Magnesium-Deficiency-in-the-Pathogenesis-of-Disease/preface.shtml
(accessed 05.12.2008).
11 Medalle, R., et al. 1976. Vitamin D resistance in magnesium deficiency.
Am. J. Clin. Nutr., 29 (8), 854–858. URL: http://www.ajcn.org/cgi/reprint/29/8/854
(accessed 05.12.2008).
12 Rude, R., & Olerich, M. 1996. Magnesium deficiency: Possible role
in osteoporosis associated with gluten-sensitive enteropathy. Osteoporosis Int.,
6 (6), 453–461. URL: http://www.ncbi.nlm.nih.gov/pubmed/9116391 (accessed
10.13.2008).
13 Cohen, L., & Kitzes, R. 1981. Infrared spectroscopy and magnesium
content of bone mineral in osteoporotic women. Israel J. Med. Sci., 17
(2), 1123–1125. URL: www.ncbi.nlm.nih.gov/pubmed/7327911 (accessed 10.13.2008).
14 Rude, R., et al. 2006. Reduction of dietary magnesium by only 50%
in the rat disrupts bone and mineral metabolism. Osteoporos. Int., 17 (7),
1022–1032. URL (abstract) http://www.ncbi.nlm.nih.gov/pubmed/16601920 (accessed
05.12.2008).
15 Sakhaee, K., et al. 2004. Stone forming risk of calcium citrate supplementation
in healthy postmenopausal women. J. Urol., 172 (3), 958–961. URL (abstract):
http://www.ncbi.nlm.nih.gov/pubmed/15311008 (accessed 05.06.2008).
16 Heller, H., et al. 2000. Pharmacokinetic and pharmacodynamics comparison
of two calcium supplements in postmenopausal women. J. Clin. Pharmacol., 40
(11), 1237–1244. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11075309 (accessed
05.28.2008).
17 Stellon, A., et al. 1985. Microcrystalline hydroxyapatite compound
in prevention of bone loss in corticosteroid-treated patients with chronic active
hepatitis. Postgrad. Med. J., 61 (719), 791–796. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=2997764
(accessed 05.01.2009).
Pines, A., et al. 1984. Clinical trial of microcrystalline hydroxyapatite
compound (‘Ossopan’) in the prevention of osteoporosis due to corticosteroid
therapy. Curr. Med. Res. Opin., 8 (10), 734–742. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/6373153
(accessed 05.01.2009).
Epstein, O., et al. 1982. Vitamin D, hydroxyapatite, and calcium gluconate
in treatment of cortical bone thinning in postmenopausal women with primary biliary
cirrhosis. Am. J. Clin. Nutr., 36 (3), 426–430. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/6287835
(accessed 05.01.2009).
Dent, C., & Davies, I. 1980. Calcium metabolism in bone disease:
Effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol.
J. R. Soc. Med., 73 (11), 780–785. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/6264079
(accessed 05.01.2009).
Nilsen, K., et al. 1978. Microcrystalline calcium hydroxyapatite compound
in corticosteroid-treated rheumatoid patients: A controlled study. Br. Med. J.,
2 (6145), 1124. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=709260
(accessed 05.01.2009).
18 Heaney, R., & Weaver, C. 2003. Calcium and vitamin D. Endocrinol.
Metab. Clin. N. Am., 32 (1), 181–194, vii–viii. URL (abstract): >http://www.ncbi.nlm.nih.gov/pubmed/12699298
(accessed 05.20.2008).
19 Murray, M., & Pizzorno, J. 1998. Encyclopedia of Natural Medicine,
459. Roseville, CA: Prima Publishing.
20 Weaver, C. 2008. The role of nutrition on optimizing peak bone mass.
Asia Pac. J. Clin. Nutr., 17 (Suppl. 1), 135–137. Review. URL (abstract):
http://www.ncbi.nlm.nih.gov/pubmed/18296321 (accessed 10.13.2008).
21 United States Department of Agriculture. Agricultural Research Service.
2002. USDA National Nutrient Database for Standard Reference, Release 21. Calcium,
Ca (mg) content of selected foods per common measure, sorted by nutrient content.
URL (PDF): http://www.nal.usda.gov/fnic/foodcomp/Data/SR21/nutrlist/sr21w301.pdf
(accessed 10.13.2008).
Further reading
United States Department of Agriculture. Agricultural Research Service. 2002. USDA
National Nutrient Database for Standard Reference, Release 21. Calcium, Ca (mg)
content of selected foods per common measure, sorted by nutrient content. URL (PDF):
http://www.nal.usda.gov/fnic/foodcomp/Data/SR21/nutrlist/sr21w301.pdf (accessed
10.13.2008).
Return to:
The calcium myth
Last Modified Date: 04/18/2011